Marshall Wace North America’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,752
Closed -$455K 2074
2018
Q4
$455K Buy
+6,752
New +$477K ﹤0.01% 797
2018
Q2
Sell
-43,971
Closed -$2.76M 1876
2018
Q1
$2.76M Buy
+43,971
New +$2.93M 0.01% 720
2017
Q4
Sell
-132,266
Closed -$10.3M 1741
2017
Q3
$10.3M Buy
+132,266
New +$10.1M 0.07% 356
2013
Q4
Sell
-27,598
Closed -$1.36M 886
2013
Q3
$1.36M Buy
+27,598
New +$1.22M 0.04% 306

Other funds holding MDSO

Marshall Wace North America's MDSO Position: Q1 2019 in Review

Marshall Wace North America sold out of Medidata Solutions, Inc. (MDSO) in Q1 2019, closing a stake of 6,752 shares — an estimated $455K sold.

Marshall Wace North America first reported a position in MDSO in Q3 2013 and held it in 4 quarters. The position peaked at $10.3M in Q3 2017. 285 funds tracked by Wall St. Rank hold MDSO as of Q1 2019.

  • Marshall Wace North America reported no remaining Medidata Solutions, Inc. position as of Q1 2019 after selling out during the quarter.
  • Marshall Wace North America sold 6,752 Medidata Solutions, Inc. shares in Q1 2019, an estimated $455K.
  • Marshall Wace North America first reported a position in Medidata Solutions, Inc. in Q3 2013 and held it in 4 quarters.
  • Marshall Wace North America's Medidata Solutions, Inc. position peaked at $10.3M in Q3 2017.
  • 285 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.